Search for: "In Re Silicone Breast Implants Liab. Litigation" Results 21 - 36 of 36
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2020, 10:37 pm by Schachtman
Singh abandoned his own interpretative principle to suit the litigation needs of the case. [read post]
2 May 2013, 9:23 am by Schachtman
  In the silicone-gel breast implant litigation, the plaintiffs’ steering committee submitted banker boxes of studies and argument to the court’s appointed expert witnesses, in an attempt to manufacture causation. [read post]
5 Jun 2013, 5:29 am by Schachtman
Supp. 1151, 1160 (E.D.La. 1997) (noting, in penile implant case, that “any” increased risk suggests that the exposure “may” have played some causal role) In re Breast Implant Litigation, 11 F. [read post]
18 Mar 2011, 10:04 am by Schachtman
August 16, 2001) (excluding causation opinion testimony given contrary epidemiologic studies; noting that sufficient epidemiologic evidence requires relative risk greater than two) In re Silicone Gel Breast Implant Litig., 318 F. [read post]
14 Aug 2011, 9:11 am by Schachtman
  In the silicone gel breast implant litigation, for instance, plaintiffs relied upon a collection of studies that looked very plausible from their peer-reviewed publications. [read post]
12 Jun 2023, 1:09 pm by admin
In scientific publishing, when scientists make a mistake, they publish an erratum or a corrigendum. [read post]
4 Mar 2012, 9:02 am by Schachtman
  Despite having case law cited to it (such as In re Ephedra), the trial court looked to the Reference Manual on Scientific Evidence, a resource that seems to be ignored by many federal judges, and rejected the bogus argument. [read post]
10 Feb 2023, 4:44 am by admin
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
23 Dec 2023, 7:16 pm by admin
“Vermin of Proof: Arguments for the Admissibility of Animal Model Studies as Proof of Causation in Toxic Tort Litigation. [read post]
25 Apr 2015, 11:03 am by Schachtman
In litigating specific causation in so-called toxic tort cases, defense counsel quickly embraced the Manual’s apparent endorsement of the doubling-of-the-risk argument, which would require relative risks in excess of two in order to draw inferences of specific causation in a given case. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
24 Mar 2017, 8:44 am by Schachtman
Evaluation of the California Talc Litigation Science Day Plaintiffs’ Presentations The presentation by the plaintiff lawyers was eerily reminiscent of the scientific case made by plaintiffs in the silicone breast implant ligation. [read post]